Dr. Mohammed Almubarak, MD
Claim this profileWest Virginia University Healthcare
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
56 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage II
Stage I
2Non-Small Cell Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Mohammed Almubarak, MD is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
More about Mohammed Almubarak, MD
Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Mohammed Almubarak, MD has experience with
- Pembrolizumab
- Biospecimen Collection
- Ipatasertib
- Binimetinib
- Paclitaxel
- APL-101
Breakdown of trials Mohammed Almubarak, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohammed Almubarak, MD specialize in?
Mohammed Almubarak, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Mohammed Almubarak, MD currently recruiting for clinical trials?
Yes, Mohammed Almubarak, MD is currently recruiting for 8 clinical trials in Morgantown West Virginia. If you're interested in participating, you should apply.
Are there any treatments that Mohammed Almubarak, MD has studied deeply?
Yes, Mohammed Almubarak, MD has studied treatments such as Pembrolizumab, Biospecimen Collection, Ipatasertib.
What is the best way to schedule an appointment with Mohammed Almubarak, MD?
Apply for one of the trials that Mohammed Almubarak, MD is conducting.
What is the office address of Mohammed Almubarak, MD?
The office of Mohammed Almubarak, MD is located at: West Virginia University Healthcare, Morgantown, West Virginia 26506 United States. This is the address for their practice at the West Virginia University Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.